Migraine enters the molecular era

Neuroscientist

Volumn 2, Issue 3, 1996, Pages 191-200

  Moskowitz, Michael A ^a   Waeber, Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

5 HT1D receptors; Trigeminovascular system

Indexed keywords

EID: 0005288165     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200314     Document Type: Article

References (58)

1. Ray BS, Wolff HG. Experimental studies on headache: pain sensitive structures of the head and their significance in headache. Arch Surg 1940;41:813-856.
2. Wolff HG. Headache and other head pain. New York: Oxford University Press 1972.
3. von Luschka H. Die Nerven in der harten Hirnhaut. Tübingen: Laupp 1850.
4. Mayberg M, Langer RS, Zervas NT, Moskowitz MA. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 1981;213:228-230.
5. Graham JR, Wolff HG. Mechanisms of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 1938;39: 737-763.
6. Branchek T. More serotonin receptors? Curr Biol 1993;3:315-317.
7. Ferrari M. Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991;325:316-321.
8. Mayberg MR, Zervas NT, Moskowitz MA. Trigeminal projections to supratentorial pial and durai blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 1984; 223:46-56.
9. O'Connor TP, van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci 1988;8: 2468-2476.
10. Liu-Chen L-Y, Mayberg MR, Moskowitz MA. Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats. Brain Res 1983;268:162-166.
11. Liu-Chen L-Y, Han DH, Moskowitz MA. Pia arachnoid contains substance P originating from trigeminal neurons. Neuroscience 1983;9:803-808.
12. McCullouch J, Uddman R, Kingman TA, Edvinsson L. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 1986;83:5731-5735.
13. Liu-Chen L-Y, Liszczak TM, King JC, Moskowitz MA. Immunoelectron microscopic study of substance P-containing fibers in feline cerebral arteries. Brain Res 1986;369:12-20.
14. B receptor antagonist in rats. J Pharmacol Exp Ther 1994;271;76-82.
15. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 1987;7:4129-4136.
16. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 1991;44:97-112.
17. Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992;48:187-203.
18. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307-311.
19. Goadsby PJ, Edvinsson L. Sumatriptan reverses the changes in CGRP seen in the headache phase of migraine. Cephalalgia 1991; 11 Suppl 11:3.
20. Buzzi MG, Dimitriadou V, Theoharides TC, Moskowitz MA. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res 1992;583:137-149.
21. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), specifically blocks neurogenic plasma extravasation from blood vessels in rat dura mater. Br J Pharmacol 1990;99: 202-206.
22. 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 1987;7:894-903.
23. 1-like receptor: six down and still counting. Trends Pharmacol Sci 1993;14:228-231.
24. Zifa E, Fillion G. 5-hydroxytryptamine receptors. Pharmacol Rev 1992;44:401-458.
25. 1D binding sites in various species: similar pharmacological profile in calf, guinea-pig, dog, monkey and human brain membranes. Naunyn Schmiedebergs Arch Pharmacol 1992;346:243-248.
26. 1D receptor genes. Trends Pharmacol Sci 1992;13;152-159.
27. 1D receptor family. EMBO J 1992;11:4779-1786.
28. Humphrey PPA, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 1993;14:233-236.
29. 1D receptors can both activate and inhibit adenylate cyclase in transfected cells. Eur J Pharmacol Mol Pharmacol Sect 1993;247: 177-184.
30. 1Dβ receptors in stably transfected fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Mol Pharmacol 1993;44:575.
31. 1Dα receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993;44:242-246.
32. 1D in the rabbit and guinea-pig brain cortex. Naunyn Schmiedebergs Arch Pharmacol 1991;343:353-364.
33. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 1994;33: 367-386.
34. Saito K, Markowitz S, Moskowitz MA. Ergot alkaloids block the neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 1988;24:732-737.
35. 1D receptor subtype. J Pharmacol Exp Ther 1990;252;387-395.
36. 1D subtype. Br J Pharmacol 1992;106:703-709.
37. 1B receptors. Mol Pharmacol 1996;49:in press.
38. 1B receptor. Science 1994;265:1875-1878.
39. Buzzi MG, Carter WB, Shimizu T, Heath H III, Moskowitz MA. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991;30:1193-1200.
40. Feniuk W, Humphrey PPA, Perren MJ. The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol 1989;96:83-90.
41. Humphrey PPA, Feniuk W, Perren MJ, Beresford IJM, Skingle M. Serotonin and migraine. Ann NY Acad Sci 1990;600:587-600.
42. Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurons only after blood-brain barrier disruption. Br J Pharmacol 1993;109:788-792.
43. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn Schmiedebergs Arch Pharmacol 1995;352:263-275.
44. Matsubara T, Moskowitz MA, Huang Z. UK-14,304, R(-)-α-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms. Eur J Pharmacol 1992;224:145-150.
45. Buzzi MG, Sakas DE, Moskowitz MA. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 1989;165:251-258.
46. 1Dα receptor gene expression in trigeminal ganglia: implications for anti-migraine drug development. Proc Natl Acad Sci USA 1994;91:3666-3669.
47. Nozaki K, Boccalini P, Moskowitz MA. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 1992;49:669-680.
48. Nozaki K, Moskowitz MA, Boccalini P. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 1992;106:409-415.
49. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine with aura: a triple-blind, placebo-controlled crossover study. Neurology 1994;44:647-651.
50. A receptor mediated effects of sodium valproate on durai plasma protein extravasation to substance P and trigeminal stimulation. Br J Pharmacol 1995;116:1661-1667.
51. A-receptor mediated effects of progesterone, its ring A-reduced metabolites and synthetic neuroactive steroids on neurogenic edema in the rat meninges. Br J Pharmacol 1996;117:99-104.
52. Cutrer FM, Limmroth V, Ayata G, Moskowitz MA. Attenruation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracistemal capsaicin. Br J Pharmacol 1995; 116:3199-3204.
53. Kraig RP, Dong L, Thisted R, Jaeger CB. Spreading depression increases immunohistochemical staining of glial fibrillary acidic protein. J Neurosci 1991;11:2187-2198.
54. Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expresion of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993;13:1167-1177.
55. Lauritzen M, Hansen AK, Kronborg D, Wieloch T. Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge. J Cereb Blood Flow Metab 1990;10:115-122.
56. Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-1692.
57. Bradley PB, Engel G, Feniuk W, et al. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986;25:563-576.
58. Hoyer D, Clarke DE, Fozard JR, et al. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.